Cryo-Cell International, Inc. (CCEL)
| Market Cap | 27.82M -39.9% |
| Revenue (ttm) | 31.28M -2.6% |
| Net Income | -2.67M |
| EPS | -0.33 |
| Shares Out | 8.06M |
| PE Ratio | n/a |
| Forward PE | 34.53 |
| Dividend | $0.15 (4.34%) |
| Ex-Dividend Date | May 21, 2025 |
| Volume | 4,513 |
| Open | 3.410 |
| Previous Close | 3.580 |
| Day's Range | 3.410 - 3.540 |
| 52-Week Range | 2.720 - 6.350 |
| Beta | 0.58 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Apr 14, 2026 |
About CCEL
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold st... [Read more]
Financial Performance
Financial StatementsNews
Cryo-Cell says NYSE American accepts compliance plan
Cryo-Cell (CCEL) announced that the NYSE American has accepted the company’s previously submitted plan to regain compliance with continued listing standards. As previously disclosed on March 12, the c...
Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced t...
Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank, has been granted renewed Foundation for the Accredit...
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced ...
Cryo-Cell Receives NYSE American Continued Listing Notice
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced t...
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...
Cryo-Cell downgraded to Hold from Buy at Maxim
Maxim analyst Allen Klee downgraded Cryo-Cell (CCEL) to Hold from Buy.
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”, “Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells ...
Cryo-Cell will not declare dividend in Q3
Cryo-Cell (CCEL) announced that the company will not declare a quarterly cash dividend for the third quarter of fiscal 2025. This decision reflects lower-than-expected profitability. Cryo-Cell may or ...
Cryo-Cell International, Inc. Provides Dividend Update
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”, “Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 1992...
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...
Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 1992, announ...
Cryo-Cell price target lowered to $8.50 from $9 at Maxim
Maxim lowered the firm’s price target on Cryo-Cell (CCEL) to $8.50 from $9 and keeps a Buy rating on the shares. The company’s Q4 adjusted EBITDA miss was likely due
Cryo-Cell reports FY24 EPS 5c vs ($1.14) last year
Reports FY24 revenue $32M vs $31.3M last year. David Portnoy, Cryo-Cell’s (CCEL) Chairman of the Board and Co-CEO remarked, “The Company’s 2024 fiscal results were impacted by continued investments re...
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...
Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 1992, announ...
CRYO-CELL International, Inc. trading resumes
09:40 EDT CRYO-CELL (CCEL) International, Inc. trading resumes
CRYO-CELL International, Inc. trading halted, volatility trading pause
09:30 EDT CRYO-CELL (CCEL) International, Inc. trading halted, volatility trading pause
Cryo-Cell initiates 25c per share quarterly dividend
Cryo-Cell (CCEL) announced that its board of directors has approved the payment of a regular quarterly cash dividend at an initial rate of 25c per share of common stock to
Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 1992, announ...
Closing Bell Movers: J.B. Hunt up 7% after Q3 earnings beat
Check out this evening’s top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGS – J.B. Hunt Transport Services (JBHT) up 6.8% Cryo-Cell International (CCEL) up 6.1% Park Aerosp...
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, anno...
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...
CRYO-CELL International, Inc. trading resumes
11:30 EDT CRYO-CELL International, Inc. trading resumes
CRYO-CELL International, Inc. trading halted, volatility trading pause
11:20 EDT CRYO-CELL International, Inc. trading halted, volatility trading pause